The stigma of alcohol-related liver disease and its impact on healthcare

Standard

The stigma of alcohol-related liver disease and its impact on healthcare. / Schomerus, Georg; Leonhard, Anya; Manthey, Jakob; Morris, James; Neufeld, Maria; Kilian, Carolin; Speerforck, Sven; Winkler, Petr; Corrigan, Patrick W.

In: J HEPATOL, Vol. 77, No. 2, 08.2022, p. 516-524.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

Schomerus, G, Leonhard, A, Manthey, J, Morris, J, Neufeld, M, Kilian, C, Speerforck, S, Winkler, P & Corrigan, PW 2022, 'The stigma of alcohol-related liver disease and its impact on healthcare', J HEPATOL, vol. 77, no. 2, pp. 516-524. https://doi.org/10.1016/j.jhep.2022.04.026

APA

Schomerus, G., Leonhard, A., Manthey, J., Morris, J., Neufeld, M., Kilian, C., Speerforck, S., Winkler, P., & Corrigan, P. W. (2022). The stigma of alcohol-related liver disease and its impact on healthcare. J HEPATOL, 77(2), 516-524. https://doi.org/10.1016/j.jhep.2022.04.026

Vancouver

Schomerus G, Leonhard A, Manthey J, Morris J, Neufeld M, Kilian C et al. The stigma of alcohol-related liver disease and its impact on healthcare. J HEPATOL. 2022 Aug;77(2):516-524. https://doi.org/10.1016/j.jhep.2022.04.026

Bibtex

@article{2123d549c54f419c98538a7bd64db7a2,
title = "The stigma of alcohol-related liver disease and its impact on healthcare",
abstract = "People with alcohol-related liver disease (ALD) experience stigma and discrimination. This review summarises the evidence on stigma in healthcare and its implications for people with ALD, drawing from the literature on the stigma associated with mental illness and, specifically, alcohol use disorder (AUD). Public stigma, self-stigma and structural stigma all contribute to failure to seek help or delays in seeking help, inferior healthcare, and negative health outcomes, which increase the overall burden of ALD. Stigma can be experienced, but also anticipated and avoided, with both scenarios negatively impacting on ALD healthcare. Blaming people with ALD for their condition is central to the stigma of ALD. Stigma affects ALD healthcare at all stages, from prevention, early detection and intervention, to allocation of scarce resources in liver transplantation. People with lived experience need to be empowered to lead action against the stigmatisation of patients with ALD. Promulgating a dynamic model of individual and social responsibility for AUD, a continuum model of harmful alcohol use, and establishing training on ALD-related stigma for healthcare professionals are strategies to address stigma. Integrating addiction and ALD services, providing stigma-free prevention, and overcoming the frequent separation of addiction services from general healthcare are necessary. Beyond healthcare, addressing social inequality, the social dimensions of ALD risk and outcomes, and ensuring equal access to services is necessary to improve outcomes for all people with ALD. More research is needed on the stigma of ALD in low- and middle-income countries and in countries with restrictive drinking norms. Interventions to reduce the stigma of ALD and facilitate early help-seeking need to be developed and evaluated.",
keywords = "Alcoholism, Delivery of Health Care, Health Personnel, Humans, Liver Diseases, Social Stigma",
author = "Georg Schomerus and Anya Leonhard and Jakob Manthey and James Morris and Maria Neufeld and Carolin Kilian and Sven Speerforck and Petr Winkler and Corrigan, {Patrick W}",
note = "Copyright {\textcopyright} 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.",
year = "2022",
month = aug,
doi = "10.1016/j.jhep.2022.04.026",
language = "English",
volume = "77",
pages = "516--524",
journal = "J HEPATOL",
issn = "0168-8278",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - The stigma of alcohol-related liver disease and its impact on healthcare

AU - Schomerus, Georg

AU - Leonhard, Anya

AU - Manthey, Jakob

AU - Morris, James

AU - Neufeld, Maria

AU - Kilian, Carolin

AU - Speerforck, Sven

AU - Winkler, Petr

AU - Corrigan, Patrick W

N1 - Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

PY - 2022/8

Y1 - 2022/8

N2 - People with alcohol-related liver disease (ALD) experience stigma and discrimination. This review summarises the evidence on stigma in healthcare and its implications for people with ALD, drawing from the literature on the stigma associated with mental illness and, specifically, alcohol use disorder (AUD). Public stigma, self-stigma and structural stigma all contribute to failure to seek help or delays in seeking help, inferior healthcare, and negative health outcomes, which increase the overall burden of ALD. Stigma can be experienced, but also anticipated and avoided, with both scenarios negatively impacting on ALD healthcare. Blaming people with ALD for their condition is central to the stigma of ALD. Stigma affects ALD healthcare at all stages, from prevention, early detection and intervention, to allocation of scarce resources in liver transplantation. People with lived experience need to be empowered to lead action against the stigmatisation of patients with ALD. Promulgating a dynamic model of individual and social responsibility for AUD, a continuum model of harmful alcohol use, and establishing training on ALD-related stigma for healthcare professionals are strategies to address stigma. Integrating addiction and ALD services, providing stigma-free prevention, and overcoming the frequent separation of addiction services from general healthcare are necessary. Beyond healthcare, addressing social inequality, the social dimensions of ALD risk and outcomes, and ensuring equal access to services is necessary to improve outcomes for all people with ALD. More research is needed on the stigma of ALD in low- and middle-income countries and in countries with restrictive drinking norms. Interventions to reduce the stigma of ALD and facilitate early help-seeking need to be developed and evaluated.

AB - People with alcohol-related liver disease (ALD) experience stigma and discrimination. This review summarises the evidence on stigma in healthcare and its implications for people with ALD, drawing from the literature on the stigma associated with mental illness and, specifically, alcohol use disorder (AUD). Public stigma, self-stigma and structural stigma all contribute to failure to seek help or delays in seeking help, inferior healthcare, and negative health outcomes, which increase the overall burden of ALD. Stigma can be experienced, but also anticipated and avoided, with both scenarios negatively impacting on ALD healthcare. Blaming people with ALD for their condition is central to the stigma of ALD. Stigma affects ALD healthcare at all stages, from prevention, early detection and intervention, to allocation of scarce resources in liver transplantation. People with lived experience need to be empowered to lead action against the stigmatisation of patients with ALD. Promulgating a dynamic model of individual and social responsibility for AUD, a continuum model of harmful alcohol use, and establishing training on ALD-related stigma for healthcare professionals are strategies to address stigma. Integrating addiction and ALD services, providing stigma-free prevention, and overcoming the frequent separation of addiction services from general healthcare are necessary. Beyond healthcare, addressing social inequality, the social dimensions of ALD risk and outcomes, and ensuring equal access to services is necessary to improve outcomes for all people with ALD. More research is needed on the stigma of ALD in low- and middle-income countries and in countries with restrictive drinking norms. Interventions to reduce the stigma of ALD and facilitate early help-seeking need to be developed and evaluated.

KW - Alcoholism

KW - Delivery of Health Care

KW - Health Personnel

KW - Humans

KW - Liver Diseases

KW - Social Stigma

U2 - 10.1016/j.jhep.2022.04.026

DO - 10.1016/j.jhep.2022.04.026

M3 - SCORING: Review article

C2 - 35526787

VL - 77

SP - 516

EP - 524

JO - J HEPATOL

JF - J HEPATOL

SN - 0168-8278

IS - 2

ER -